Autism - Pipeline Review, H2 2014
Global Markets Direct's, 'Autism - Pipeline Review, H2 2014', provides an overview of the Autism's therapeutic pipeline.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
• The report provides a snapshot of the global therapeutic landscape of Autism
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Autism and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• Latest news and deals relating related to pipeline products
For more Information About Autism - Pipeline Review, H2 2014 Click:
http://www.radiantinsights.com/research/autism-pipeline-review-h2-2014
Asthma - Pipeline Review, H2 2014
Global Markets Direct's, 'Asthma - Pipeline Review, H2 2014', provides an overview of the Asthma's therapeutic pipeline.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
• The report provides a snapshot of the global therapeutic landscape of Asthma
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Asthma and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
For more Information About Asthma - Pipeline Review, H2 2014 Click:
http://www.radiantinsights.com/research/asthma-pipeline-review-h2-2014
Acne Vulgaris - Pipeline Review, H2 2014
Global Markets Direct's, 'Acne Vulgaris - Pipeline Review, H2 2014', provides an overview of the Acne Vulgaris's therapeutic pipeline.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
• The report provides a snapshot of the global therapeutic landscape of Acne Vulgaris
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Acne Vulgaris and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• Latest news and deals relating related to pipeline products
For more Information About Acne Vulgaris - Pipeline Review, H2 2014 Click:
http://www.radiantinsights.com/research/acne-vulgaris-pipeline-review-h2-2014
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Blog URL: http://www.terrapass.org/
Media ContactCompany Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist - USA
Email:Send Email
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/autism-pipeline-review-h2-2014
